Jolla Pharmaceutical Company (Nasdaq: LJPC) (the “Company” or “La
Jolla”), a leader in the development of therapeutics targeting
significant unmet life-threatening diseases, today announced that George
Tidmarsh, MD, Ph.D., President and Chief Executive Officer, will provide
a corporate overview at the 9th Annual JMP Securities Healthcare
Conference taking place June 24-25 in New York City.
for La Jolla Pharmaceutical Company to Provide Corporate Overview at the 9th Annual JMP Securities Healthcare Conference investment picks